Purpose: This study evaluated the hepatoprotective effects and safety profile of donafenib combined with transarterial chemoembolization (TACE) in unresectable hepatocellular carcinoma (HCC) through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback